Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

The Effects of Virtual Reality-Based Relaxation on Postoperative Symptoms and Patient Satisfaction Among Adolescents Undergoing Emergency Surgery

16. November 2026 aktualisiert von: Aynur Çakmak, Dokuz Eylul University

Investigation of the Effects of Virtual Reality-Based Relaxation Exercises on Postoperative Symptom Management and Patient Satisfaction in Adolescents Undergoing Emergency Surgical Intervention

The aim of this study is to evaluate the effects of virtual reality-based progressive relaxation exercises on surgery-related symptoms and patient satisfaction among adolescents undergoing emergency surgery. Specifically, the study will investigate the effects of these exercises on preoperative and postoperative anxiety levels, pain intensity scores, nausea and vomiting scores, time to mobilization (hours), total length of hospital stay (hours), and patient satisfaction.

Studienübersicht

Detaillierte Beschreibung

The aim of this study is to evaluate the effects of virtual reality-based progressive relaxation exercises on surgery-related symptoms and patient satisfaction in adolescents undergoing emergency surgical procedures. Specifically, the study will examine the effects of this intervention on preoperative and postoperative anxiety levels, pain intensity, nausea and vomiting severity, time to first mobilization (hours), total length of hospital stay (hours), and patient satisfaction.

Studientyp

Interventionell

Einschreibung (Geschätzt)

60

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studieren Sie die Kontaktsicherung

Studienorte

    • Balçova
      • Izmir, Balçova, Türkei (türkiye)
        • Dokuz Eylül University Research and Application Hospital

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

12 Jahre bis 18 Jahre (Kind, Erwachsene)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Inclusion Criteria:
  • Adolescents aged 12-18 years who voluntarily agree to participate in the study,
  • Undergoing surgery for the first time,
  • Scheduled to undergo emergency surgery within 24 hours of hospital admission (appendicitis, ovarian torsion, testicular torsion, or Meckel's diverticulum),
  • Having no chronic diseases (e.g., diabetes, hypertension, asthma, cerebral palsy, epilepsy, cystic fibrosis, etc.),
  • Having no visual, hearing, or physical disabilities,
  • Being oriented to person, place, and time,
  • Having no cognitive impairment that would affect their ability to express themselves,
  • Adolescents for whom written informed consent has been obtained from both the adolescent and their parent.

Exclusion Criteria:

  • Adolescents who do not complete all stages of the study,
  • Adolescents who are admitted to the intensive care unit after surgery,
  • Adolescents whose surgery is postponed beyond the first 24 hours,
  • Adolescents who undergo surgery due to perforated appendicitis,
  • Adolescents diagnosed with migraine, vertigo, or similar conditions,
  • Adolescents who experience hemodynamic instability when wearing the VR headset.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Unterstützende Pflege
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Intervention Group: Virtual Reality

Adolescents and their parents will be informed about the study, and written informed consent will be obtained. Baseline data will be collected using the Adolescent Descriptive Characteristics Form, Vital Signs Monitoring Form, Visual Analog Scale (VAS), and Spielberger State Anxiety Inventory (STAI-S). Participants will receive instructions on VR headset use and relaxation exercises. Before surgery, vital signs, pain, and anxiety will be reassessed. Postoperatively, vital signs, pain, anxiety, and nausea (BARF scale) will be evaluated. At the fourth postoperative hour, following adequate recovery from anesthesia, the VR-based relaxation intervention will be administered. All clinical outcomes will be reassessed at the sixth postoperative hour. Before discharge, patient satisfaction (VAS-S), time to first mobilization, and length of hospital stay will be recorded.

The virtual reality (VR) intervention was implemented using an Oculus Quest 2 headset, selected to ensure patient safety and ease of use. The device is rechargeable, operates independently without requiring a computer connection, weighs 503 g, and is secured to the user's head using adjustable, soft straps. Its hand-tracking feature enables participants to interact naturally with virtual environments using their own hands, without the need for handheld controllers.

The VR-based relaxation program lasts 16 minutes and incorporates rhythmic breathing, controlled exhalation, and progressive muscle relaxation exercises. The progressive muscle relaxation component targets several muscle groups, including the arms and hands, neck, chest and abdomen, legs and hips, back and shoulders, eyes and head, and feet and lower legs.

Kein Eingriff: Control Group: Standard Care

During the preoperative period, adolescents and their parents will be informed about the surgical process, and appropriate measures will be taken to ensure patient safety. Adolescents and their parents will also be informed about the study, and written informed consent will be obtained from both parties. During the initial face-to-face interview, data will be collected using the Adolescent Descriptive Characteristics Form, Vital Signs Monitoring Form, Visual Analog Scale (VAS), and Spielberger State-Trait Anxiety Inventory - State Version (STAI-S). Demographic and clinical data will be obtained from the adolescents, their parents, and medical records. Before surgery, vital signs, pain intensity, and state anxiety levels will be reassessed. At the fourth postoperative hour, vital signs, pain intensity, state anxiety, and nausea will be assessed using the BARF scale, while routine nursing care will be provided. At the sixth postoperative hour, these clinical outcomes will be reassessed.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Preoperative Anxiety Level
Zeitfenster: 6 months

Anxiety will be assessed using the Spielberger State Anxiety Inventory (STAI-S), a 20-item scale with total scores ranging from 20 to 80, with higher scores indicating higher levels of anxiety. Two assessments will be conducted during the preoperative period: the first immediately upon the patient's arrival at the surgical ward and the second 30 minutes before transfer to the operating room.

6 months
Postoperative Anxiety Level
Zeitfenster: 6 months

Postoperative anxiety will be assessed on postoperative day 0 using the Spielberger State Anxiety Inventory (STAI-S), a 20-item self-report instrument scored on a 4-point Likert scale, with total scores ranging from 20 to 80. Higher scores indicate greater levels of postoperative anxiety. Assessments will be conducted at two time points: 4 and 6 hours after surgery (postoperative day 0).

6 months
Postoperative Pain Intensity
Zeitfenster: 6 months

Postoperative pain intensity will be assessed on postoperative day 0 (POD 0) using a 10-cm Visual Analog Scale (VAS), with scores ranging from 0 to 10. A score of 0 indicates no pain, whereas a score of 10 represents the worst imaginable pain. Assessments will be performed at 4 and 6 hours after surgery.

6 months

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Postoperative Nausea Severity
Zeitfenster: 6 months

Postoperative nausea severity will be assessed using the Baxter Retching Faces (BARF) Scale, with scores ranging from 0 to 10. A score of 0 indicates no nausea, whereas a score of 10 represents the most severe nausea. Assessments will be conducted at two time points: 4 and 6 hours after surgery.

6 months
Postoperative Length of Hospital Stay
Zeitfenster: 6 months

Total duration of postoperative hospitalization, measured in hours from the completion of the surgical procedure until the adolescent patient is formally discharged from the hospital.

6 months
Patient satisfaction level
Zeitfenster: 6 months

Visual Analog Scale for Satisfaction (VAS-S): Patient satisfaction with nursing care will be assessed using a 10-cm visual analog scale ranging from 0 (not satisfied at all) to 10 (completely satisfied), with higher scores indicating greater satisfaction. The assessment will be performed at the 6th postoperative hour on the day of surgery (POD 0).

6 months
At the First Postoperative Mobilization Session
Zeitfenster: 6 months

The total duration (in minutes) of active ambulation performed by the adolescent patient during the first postoperative mobilization session on postoperative day 0 (POD 0).

6 months

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

20. November 2026

Primärer Abschluss (Geschätzt)

10. April 2027

Studienabschluss (Geschätzt)

10. August 2027

Studienanmeldedaten

Zuerst eingereicht

4. November 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

16. November 2026

Zuerst gepostet (Tatsächlich)

18. November 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

18. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

16. November 2026

Zuletzt verifiziert

1. November 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • DEU-SBF-AC-01

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren